Overview of the TB epidemic globally and in India
|
|
|
- Bertram Stanley
- 5 years ago
- Views:
Transcription
1 Overview of the TB epidemic globally and in India Dr Soumya Swaminathan Deputy Director General for Programmes 5 th GLOBAL FORUM ON TB VACCINES PARTNERING FOR PROGRESS AND INNOVATION February 20, 2018 New Delhi, India
2 UN Sustainable Development Goals WHO End TB Strategy Target 3.3: By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases Goal: End the global TB epidemic WHO s 5 year strategic plan also has a flagship program on Eliminating and Controlling Communicable Diseases Common aim: end the global TB epidemic
3 Two overarching messages 1. Burden of TB disease still high, affecting all countries, all ages, men, women and children 2. There is progress, but it is slow - not fast enough to reach targets or make major headway in closing persistent gaps
4 TB is one of top 10 causes of death worldwide ranks 9 th, top infectious disease killer Ischaemic heart disease Stroke Lower resp. infections COPD Cancer: tracheal, bronchus, lung Diabetes Alzheimers, other dementias Diarrheal diseases TB Road injuries TB TB deaths among HIV-positive people Millions in 2015
5 The Global Burden of TB, 2016 Estimated number of cases Estimated number of deaths All forms of TB 10.4 million 142 per 100, million* HIV associated TB 1.04 million (10%) 400,000 Multidrug resistant TB MDR/RR 490, , ,000 Source: WHO Global TB Report 2016 * Including deaths attributed to HIV/TB
6 TB is in every country Highest incidence rates in Africa and parts of Asia Incidence per pop per year % South-East Asia, 25% Africa, 17% Western Pacific, 7% Eastern Mediterranean, 3% Americas, 3% Europe
7 5 countries = 56% of cases in countries account for 64% Number of incident cases Nigeria Pakistan India China Philippines Indonesia South Africa circles shown for countries with at least 100,000 incident cases in 2016
8 Case notifications increasing but large incidence: notification gap Number of cases globally (millions) Incidence 10.4 Case notifications (61% of incidence in 2016) Treatment success 83% globally in 2015, as in million cases Underreporting, under-diagnosis
9 Millions of people with TB successfully treated each year 56 million, Millions Successfully treated Died/failed treatment/ lost to follow-up Not evaluated
10 MDR/RR-TB: 3 countries, 47% cases Russian Federation China Number of incident cases India circles shown for countries with at least 1000 incident cases in 2016
11 MDR-TB remains a public health crisis cases of MDR TB estimated in % 50% Three out of the 27 high MDR TB countries achieved a treatment success rate of 75%
12 India: high TB, high MDR-TB, high TB-HIV burden country 56% of TB incidence occurs in five countries: India, Indonesia, China, the Philippines and Pakistan. Global TB Report 2017
13 Estimated incidence of MDR/RR TB in 2016, for countries with at least 1000 incident cases Global TB Report 2017 The countries with the largest numbers of MDR/RR TB cases (47% of the global total) were China, India and the Russian Federation.
14 Tuberculosis in India: Progress Declining mortality rate from TB (excluding HIV), big achievement in light of large population Decline in the Incidence of TB and increase in notification However, still 25% of the missing 4 million people with TB in 2016 in 2016 were in India. Global TB Report 2017
15 Tuberculosis in India: Challenges Poor treatment success rate for MDR/XDR-TB India relying on international financing for 25% of TB budget Only 22% of the estimated cases of rifampicinresistant TB and DR TB globally started treatment; India and China accounted for 39% of the global gap. Other challenges: socio economic determinants, weak health system, suboptimal public private engagement Global TB Report 2017
16 Political Commitment to End TB in India Public private engagement to increase notification, as well as to improve and mainstream the diagnosis and treatment pathway Increasing treatment access and coverage Multisectoral approach Addressing economic barriers, psycho social support, delivery, etc. Making patient centred care front and centre Research and development Develop more effective, affordable biomedical tools adaptable to country context including diagnostics, drugs and vaccines (collaboration and investment) Innovative health systems and social science interventions that improve service delivery (patient centred care) Global TB Report 2017
17 RePORT India Consortium A model for international partnerships Bilateral, multi organizational collaborative initiative sponsored by the US and Indian Governments under the auspices of INDO US Vaccine Action Program (VAP) to address the threat of TB in India and across the globe US: The National Institute of Allergy and Infectious Diseases (NIAID/NIH) India: The Government of India s Department of Biotechnology (DBT) and the Indian Council of Medical Research (ICMR) MISSION: Advance regional TB science in India Strengthen TB research capacity and infrastructure in India Foster research collaboration within India and internationally, with the aim of carrying out a range of basic and clinical research that can lead to clinically important biomarkers, vaccines, drugs, and diagnostics
18 What is RePORT India Consortium? 6 unique observational TB cohorts in India conducting Parent Protocols since sites conducting the Common Protocol since 2017 Evaluate TB disease (Cohort A) and TB infection (Cohort B) Coordinated by leadership group Composed of PIs, funders, representatives from Westat/PPD, CRDF, SAS CHRD Each cohort linked by Common Protocol, Central SDMC and Central repository Maintain unique research interests while facilitating GOAL: To create a resource for the TB research community collaborative research of a collection of well characterized and standardized samples with accompanying data to investigate critical TB research questions
19 RePORT India Sites Hinduja Mumbai BJMC Pune BMMRC Hyderabad CMC Vellore NIRT Chennai MVDRC Chennai JIPMER Pondichery
20 Age specific prevalence of TB infection among Indian household contacts of adult PTB cases CTRIUMPh RePORT India cohort, n=1047 at least TST+ at least QFT+ Prevalence % Both TST+/QFT+ TST+/QFT TST /QFT+ Both TST /QFT Submitted for publicatio
21 RePORT International Consortia RePORT India 2012 RePORT Brazil 2013 RePORT Indonesia 2014 RePORT South Africa 2016 RePORT China 2017 RePORT Philippines 2018 RePORT International Coordinating Center (RICC) 2016
22 India TB Research Consortium Formed to address gaps in R&D funding for TB Focused on translational research to develop and validate new tools Completed 100 site field testing of Truenat, a new POC molecular diagnostic for TB and RRTB 4 multi centric clinical trials for DSTB and M/XDRTB treatment planned Vaccine trial with MIP and VPM1002 to prevent TB among household contacts Linking with international networks eg BRICS would be welcome
23 Acknowledgements WHO/GTB Team Katherine Floyd, Philippe Glaziou, Nebiat Gebreselassie, Christian Lienhardt, (Mario Raviglione), Tereza Kasaeva WHO Regional Offices Regional Offices: Mohamed Abdel Aziz, Masoud Dara, Daniel Kibuga, Partha Mandal, Rafael Lopez- Olarte, Nobu Nishikiori > 500 people who contributed to reporting and review of data Dr Amita Gupta, JHU Dr Manjula Singh and Dr Sanjay Mehendale, ICMR
The WHO END-TB Strategy
ENDING TB and MDR-TB The WHO END-TB Strategy Dr Mario RAVIGLIONE Director Joint GDI/GLI Partners Forum WHO Geneva, 27 April 2015 This talk will deal with TB Burden Progress, Challenges Way Forward Who
TB 2015 burden, challenges, response. Dr Mario RAVIGLIONE Director
TB 2015 burden, challenges, response Dr Mario RAVIGLIONE Director Addis Ababa, Ethiopia 11-13 November 2015 Overview TB basics TB burden & challenges Response: End TB Strategy DAY 1 What is TB? Definition
THE Price of a Pandemic 2017
THE Price of a Pandemic 2017 From 2000-2015: 33 million people died because of TB at a global economic cost of $617bn This report was produced the Global TB Caucus, an international network of over 2,000
The United Nations flag outside the Secretariat building of the United Nations, New York City, United States of America
The United Nations flag outside the Secretariat building of the United Nations, New York City, United States of America Mike Segar / Reuters Executive Summary Context On 26 September 2018, the United Nations
Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues
EXECUTIVE BOARD EB44/ 44th session December 08 Provisional agenda item 5.8 Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues Ending tuberculosis Report
Global TB control: Current status with particular attention to TB among women and children
Global TB control: Current status with particular attention to TB among women and children Katherine Floyd Stop TB Department World Health Organization 42 nd Union World Conference on Lung Health Stop
Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB
February 2017 Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB 1. Background TB is the leading cause of death by infectious disease, killing 1.8 million people in 2015. Each
WHO Global Task Force on TB Impact Measurement An overview
WHO Global Task Force on TB Impact Measurement An overview Katherine Floyd (WHO/GTB/TME) 3 rd meeting of the TB estimates subgroup Glion-sur-Montreux, 31March 2 April 2015 GLOBAL TB PROGRAMME 1. Broad
The epidemiology of tuberculosis
The epidemiology of tuberculosis Tuberculosis Workshop Shanghai, 12-22 May 28 Philippe Glaziou World Health Organization Outline Epidemiology refresher Estimates of tuberculosis disease burden Notifications
Global, National, Regional
Epidemiology of TB: Global, National, Regional September 13, 211 Edward Zuroweste, MD Chief Medical Officer Migrant Clinicians Network Assistant Professor of Medicine Johns Hopkins School of Medicine Epidemiology
GLOBAL TUBERCULOSIS REPORT EXECUTIVE SUMMARY
GLOBAL TUBERCULOSIS REPORT EXECUTIVE SUMMARY 2018 Context On 26 September 2018, the United Nations (UN) will hold its first highlevel meeting on tuberculosis (TB), at its headquarters in New York. The
Suraj Madoori, Treatment Action Group, U.S. and Global Health Policy Director. On behalf of the Tuberculosis Roundtable
United States House of Representatives Committee on Appropriations Subcommittee on State and Foreign Operations and Related Programs Fiscal Year 2020 Written Testimony Suraj Madoori, Treatment Action Group,
CHAIR: DR JORGE SAMPAIO, UN SECRETARY-GENERAL'S SPECIAL ENVOY TO STOP TB AND FORMER PRESIDENT OF THE PORTUGUESE REPUBLIC
PROVISIONAL AGENDA WEDNESDAY 1 APRIL 2009 SESSION 1: THE CHALLENGE OF M/XDR-TB: GLOBAL AND NATIONAL LEADERSHIP CHAIR: DR JORGE SAMPAIO, UN SECRETARY-GENERAL'S SPECIAL ENVOY TO STOP TB AND FORMER PRESIDENT
La Lotta alla Tubercolosi. Matteo Zignol and Mario C. Raviglione Stop TB Department WHO, Geneva, Switzerland. Geneva March 2012
La Lotta alla Tubercolosi Matteo Zignol and Mario C. Raviglione Stop TB Department WHO, Geneva, Switzerland Geneva 19-20 March 2012 Overview of the presentation The global burden of tuberculosis The WHO
Global, National, Regional
Epidemiology of TB: Global, National, Regional September 13, 211 Edward Zuroweste, MD Chief Medical Officer Migrant Clinicians Network Assistant Professor of Medicine Johns Hopkins School of Medicine Epidemiology
Post-2015 TB Elimination Strategy and Targets
Photo: Riccardo Venturi Vision and proposed framework for a Post-2015 TB Elimination Strategy and Targets Consultation on Eliminating the catastrophic economic burden of TB" Universal Health Coverage and
Contextual overview with reference to MDG Goal 6 and projection for Post-2015
Contextual overview with reference to MDG Goal 6 and projection for Post-2015 10th Partnership Annual Conference Side Event Combating HIV and TB through a joint regional action Helsinki, Finland November
Stop TB Working Group on DOTS-Plus for MDR-TB Strategic Plan
Stop TB Working Group on DOTS-Plus for MDR-TB Strategic Plan 2006-2015 Background Current threat and status of the global epidemic of multidrug resistant tuberculosis (MDR-TB) Along with HIV/AIDS, MDR-TB
Monitoring of the achievement of the health-related Millennium Development Goals
SIXTY-THIRD WORLD HEALTH ASSEMBLY WHA63.15 Agenda item 11.4 21 May 2010 Monitoring of the achievement of the health-related Millennium Development Goals The Sixty-third World Health Assembly, Having considered
Finding the missing TB cases
Finding the missing TB cases Optimizing strategies to enhance case detection in high HIV burden settings Dr Malgosia Grzemska Global TB Programme, WHO/HQ, Geneva SWITZERLAND Child and Adolescent TB Working
Okinawa, Toyako, and Beyond: Progress on Health and Development
Okinawa, Toyako, and Beyond: Progress on Health and Development Prof. Michel D. Kazatchkine Executive Director The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations University, Tokyo,
MODULE SIX. Global TB Institutions and Policy Framework. Treatment Action Group TB/HIV Advocacy Toolkit
MODULE SIX Global TB Institutions and Policy Framework Treatment Action Group TB/HIV Advocacy Toolkit 1 Topics to be Covered Global TB policy and coordinating structures The Stop TB Strategy TB/HIV collaborative
Latest Funding Trends in AIDS Response
Latest Funding Trends in AIDS Response 20 th International AIDS Conference Melbourne, Australia J.V.R. Prasada Rao United Nations Secretary-General s Special Envoy for AIDS in Asia and the Pacific 21 July
OPERATIONAL FRAMEWORK. for the Global Strategy for Women s, Children s and Adolescents Health
OPERATIONAL FRAMEWORK for the Global Strategy for Women s, Children s and Adolescents Health Every Woman Every Child 2016 OPERATIONAL FRAMEWORK for the Global Strategy for Women s, Children s and Adolescents
In 2013, around 12.9 million people living with HIV had access to antiretroviral therapy.
F A C T S H E E T 2014 GLOBAL STATISTICS People living with HIV In 2013, there were 35 [33.2 37.2 ] people living with HIV. - Since the start of the epidemic, around 78 [71 87 ] people have become infected
TB epidemic and progress towards the Millennium Development Goals
Open Forum 4: Key issues in TB Drug Development, August 18, 2010, Addis Ababa, Ethiopia TB epidemic and progress towards the Millennium Development Goals Haileyesus Getahun Stop TB Department, WHO Geneva,
Media Coverage World Health Organisation Grants Prequalification to Bharat Biotech s rotavirus vaccine, ROTAVAC(R)
Media Coverage World Health Organisation Grants Prequalification to Bharat Biotech s rotavirus vaccine, ROTAVAC(R) 1) Business Wire World Health Organization Grants Prequalification to Bharat Biotech s
Technology and innovation: Changing dynamics of TB control. Karin Weyer
Technology and innovation: Changing dynamics of TB control Karin Weyer Latest news 1. New tools finally a reality 2. Universal access for all affected from TB 3. Emphasis on early case detection and treatment
2010 global TB trends, goals How DOTS happens at country level - an exercise New strategies to address impediments Local challenges
Outline of what it will take Tuberculosis Elimination 25: Global and Local Challenges Anne Fanning, MD November 9, 211 21 global TB trends, goals How DOTS happens at country level - an exercise New strategies
Towards universal access
Key messages Towards universal access Scaling up priority HIV/AIDS interventions in the health sector September 2009 Progress report Towards universal access provides a comprehensive global update on progress
Progress on the targets of Millennium Development Goal 6 in central and eastern Europe and central Asia
Progress on the targets of Millennium Development Goal 6 in central and eastern Europe and central Asia 11 October 2011 Moscow, Russian Federation Zsuzsanna Jakab WHO Regional Director for Europe Millennium
Since the start t of the HIV/ 1980 s: 77.3 million people have be. In million people were liv
The HIV/AIDS Epidemic and Sustainable Development tgoals Etienne Karita, MD MSc MSPH Kigali, 8 Nov 018 IV/AIDS Burden Since the start t of the HIV/ V/AIDS epidemic i in the early 1980 s: 77.3 million people
Drug-resistant Tuberculosis
page 1/6 Scientific Facts on Drug-resistant Tuberculosis Source document: WHO (2008) Summary & Details: GreenFacts Context - Tuberculosis (TB) is an infectious disease that affects a growing number of
UN HIGH-LEVEL MEETING ON TB KEY TARGETS & COMMITMENTS FOR 2022
UN HIGH-LEVEL MEETING ON TB KEY TARGETS & COMMITMENTS FOR 2022 UNHLM ON TB KEY TARGETS FOR 2022 WE, HEADS OF STATE AND GOVERNMENT AND REPRESENTATIVES OF STATES AND GOVERNMENTS ASSEMBLED AT THE UNITED NATIONS
ENDING AIDS, TB AND MALARIA AS EPIDEMICS
ENDING AIDS, TB AND MALARIA AS EPIDEMICS A SMART INVESTMENT In 2000, AIDS, tuberculosis and malaria appeared to be unstoppable. In many countries, AIDS devastated an entire generation, leaving countless
DEVELOPMENT. The European Union confronts HIV/AIDS, malaria and tuberculosis. A comprehensive strategy for the new millennium EUROPEAN COMMISSION
DEVELOPMENT The European Union confronts HIV/AIDS, malaria and tuberculosis A comprehensive strategy for the new millennium EUROPEAN COMMISSION DE 121 FEB 2004 A global challenge Every minute, 11 people
WHERE DO WE GO FROM HERE?
WHERE DO WE GO FROM HERE? WHAT WILL BE REQUIRED TO ACHIEVE ZERO DEATHS FROM TUBERCULOSIS? SALMAAN KESHAVJEE, MD, PHD, SCM HARVARD MEDICAL SCHOOL BRIGHAM AND WOMEN S HOSPITAL PARTNERS IN HEALTH INTERNATIONAL
SOUTH AFRICA S TB BURDEN - OVERVIEW
SOUTH AFRICA S TB BURDEN - OVERVIEW Dr Aaron Motsoaledi, MP: Chairperson of the Board, Stop TB Partnership Minister of Health, South Africa 31 January 2014, Cape Town South Africa s TB Burden Global TB
Working for an International Organization in Public-Private Partnership : The Global Fund to Fight AIDS, Tuberculosis and Malaria
Working for an International Organization in Public-Private Partnership : The Global Fund to Fight AIDS, Tuberculosis and Malaria Birgit Poniatowski Acting Manager, Board Relations Overview The Global
Tuberculosis-related deaths in people living with HIV have fallen by 36% since 2004.
F A C T S H E E T 2014 GLOBAL STATISTICS People living with HIV In 2013, there were 35 [33.2 37.2 ] people living with HIV. - Since the start of the epidemic, around 78 [71 87 ] people have become infected
ART for prevention the task ahead
ART for prevention the task ahead Dr Teguest Guerma WHO/HQS WHO's role and vision Status of the epidemic Overview Progress and challenges in treatment and prevention scale up ART for prevention Questions
Why Non communicable Diseases? Why now?
Why Non communicable Diseases? Why now? Professor Michelle A. Williams Chair, Department of Epidemiology Harvard School of Public Health November 8, 2012 Addis Ababa, Ethiopia Non communicable Diseases
ENDING AIDS, TB AND MALARIA AS EPIDEMICS
ENDING AIDS, TB AND MALARIA AS EPIDEMICS A SMART INVESTMENT In 2000, AIDS, tuberculosis and malaria appeared to be unstoppable. In many countries, AIDS devastated an entire generation, leaving countless
BD-PEPFAR Labs for Life Partnership
BD-PEPFAR Labs for Life Partnership Renuka Gadde BD Global Health Jane Mwangi Division of Global HIV & TB, CDC Kenya FORUM ON PUBLIC-PRIVATE PARTNERSHIPS FOR GLOBAL HEALTH AND SAFETY October 27-28, 2016
GLOBAL STATISTICS FACT SHEET 2015
FACT SHEET 2015 GLOBAL STATISTICS 15.8 people accessing antiretroviral therapy (June 2015) 36.9 [34.3 41.4 ] people globally were living with HIV (end 2014) 2 [1.9 2.2 ] people became newly infected with
The Global Cancer Epidemic. Tim Byers MD MPH Colorado School of Public Health
The Global Cancer Epidemic Tim Byers MD MPH Colorado School of Public Health This year there will be more deaths in the World from cancer than from: Combined This year there will be more deaths in the
GLOBAL HEALTH SPESIALISERING IN. Austen Davis
GLOBAL HEALTH SPESIALISERING IN SAMFUNNSMEDISIN 16.02.2016 Austen Davis SUSTAINABLE DEVELOPMENT GOALS THE POST 2015 AGENDA Where do we come from? 14 th C quarantine Tropical Health International Health
THE GLOBAL STRATEGY FOR WOMEN S, CHILDREN S AND ADOLESCENTS HEALTH ( )
THE GLOBAL STRATEGY FOR WOMEN S, CHILDREN S AND ADOLESCENTS HEALTH (2016-2030) SURVIVE THRIVE TRANSFORM AT A GLANCE SURVIVE THRIVE TRANSFORM The Global Strategy for Women s, Children s and Adolescents
Revitalising community engagement for TB and TB/HIV prevention, diagnosis and treatment
17 th TB/HIV Core Group meeting, Beijing, China. November 11, 2011 Revitalising community engagement for TB and TB/HIV prevention, diagnosis and treatment Haileyesus Getahun Stop TB Department WHO Outline
Epidemiology of chronic diseases in developing countries. Prof Isaac Quaye, UNAM SOM
Epidemiology of chronic diseases in developing countries Prof Isaac Quaye, UNAM SOM Synopsis Definitions: epidemiology/chronic disease Changing trends in disease epidemiology towards non communicable Core
Global MDR-TB Update GIDC. Paul Nunn, MA, FRCP(UK) Director, Global Infectious Disease Consulting London, UK
Global MDR-TB Update Paul Nunn, MA, FRCP(UK) Director, Global Infectious Disease Consulting London, UK Acknowledgements Matteo Zignol Mario Raviglione All the WHO staff in drug resistance surveillance
MEETING OF INTERESTED PARTIES
WORLD HEALTH ORGANIZATION MEETING OF INTERESTED PARTIES GENEVA, 3 TO 7 NOVEMBER 2003 Timetable and annotated agenda Please note that the timetable is indicative and that the timing of discussions may vary
The Western Pacific Region faces significant
COMBATING COMMUNICABLE DISEASES A medical technician draws blood for HIV screening in Manila. AFP elimination of mother-to-child transmission of HIV and congenital syphilis was piloted in Malaysia and
Graduating from missing linkages to value propositions to patient-centered approaches
Graduating from missing linkages to value propositions to patient-centered approaches Lynette Mabote Programmes Lead AIDS and Rights Alliance for Southern Africa (ARASA) The Architecture of a Biomedical
Recipients of development assistance for health
Chapter 2 Recipients of development assistance for health Both low- and middle-income countries are eligible for development assistance for health (DAH). In addition to income, burden of disease, which
5 th Islamic Conference of Health Ministers. Resolution. Istanbul, Turkey November 2015 (5-7 Safar 1437H)
5 th Islamic Conference of Health Ministers Resolution Istanbul, Turkey 17-19 November 2015 (5-7 Safar 1437H) Draft Resolution No. 2/5-ICHM On Healthy Life Style, Prevention and Control of Communicable
Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections ( )
Regional Committee for Europe 65th session EUR/RC65/Inf.Doc./3 Vilnius, Lithuania, 14 17 September 2015 2 September 2015 150680 Provisional agenda item 3 ORIGINAL: ENGLISH Global health sector strategies
The outlook for hundreds of thousands adolescents is bleak.
Adolescents & AIDS Dr. Chewe Luo Chief HIV/AIDS, UNICEF Associate Director, Programmes Division 28/11/17 Professor Father Micheal Kelly Annual Lecture on HIV/AIDS Dublin, Ireland The outlook for hundreds
TB Vaccine Development Strategy Overview
TB Vaccine Development Strategy Overview October 28, 2014 Angeline Nanni, MBA, MS Aeras Director, Global Access TB is Mother Nature s number one killer over the past centuries TB is spread through the
ENHANCING AFRICA S PUBLIC HEALTH RESPONSE THROUGH INNOVATION AND PARTNERSHIPS
ENHANCING AFRICA S PUBLIC HEALTH RESPONSE THROUGH INNOVATION AND PARTNERSHIPS Strategic plan for the Africa CDC March 24-25, 2017 The Ebola outbreak underscored the fact that 2 pandemics are not just a
Childhood Vaccination and Immunisation
DIRECTORATE GENERAL FOR INTERNAL POLICIES POLICY DEPARTMENT A: ECONOMIC AND SCIENTIFIC POLICY WORKSHOP Childhood Vaccination and Immunisation Brussels, 19 June 2013 MEETING DOCUMENT Policy Department A:
Overall presentation of IVR Strategy
Annex 3 Overall presentation of IVR Strategy Presentation to the IVR Advisory committee (IVAC) April 2007 Outline Why does WHO invest in Research & Development? What is the Initiative for Vaccine Research
AIDS Funding Landscape in Asia and the Pacific
Agenda 3: Country experiences and plans towards sustainable AIDS financing AIDS Funding Landscape in Asia and the Pacific J.V.R. Prasada Rao United Nations Secretary-General s Special Envoy for AIDS in
Accelerating progress towards the health-related Millennium Development Goals
Accelerating progress towards the health-related Millennium Development Goals The critical role of the national health policy & strategy in strengthening health systems and delivering effective interventions
Tuberculosis: Opportunities and Challenges for Achieving HIV Epidemic Control
Tuberculosis: Opportunities and Challenges for Achieving HIV Epidemic Control Suvanand Sahu Deputy Executive Director Stop TB Partnership Secretariat Tuberculosis TB epidemic is declining very slowly We
The Global Fund & UNICEF Partnership
The Global Fund & UNICEF Partnership Prof Michel D. Kazatchkine Executive Director UNICEF Executive Board February 9 th, 2011 The Global Fund Millennium Development Goals 1. Eradicate extreme poverty and
PROVISIONAL SUMMARY RECORD OF THE EIGHTH MEETING
SEVENTY-FIRST WORLD HEALTH ASSEMBLY COMMITTEE A A71/A/PSR/8 4 July 2018 PROVISIONAL SUMMARY RECORD OF THE EIGHTH MEETING Palais des Nations, Geneva Wednesday, 24 May 2018, scheduled at 14:30 Chairman:
Resolutions of the 50 th East, Central and Southern African Health Ministers Conference
50 th ECSA HMC East, Central and Southern African Health Community ECSA-HC February 2010 Resolutions of the 50 th East, Central and Southern African Health Ministers Conference Serena Hotel, Kampala Uganda
Theresa NeSmith Centers for Disease Control and Prevention Center for Global Health Division of Global HIV/AIDS International Laboratory Branch
Theresa NeSmith Centers for Disease Control and Prevention Center for Global Health Division of Global HIV/AIDS International Laboratory Branch PEPFAR Laboratory Program is a Critical Part of Health Systems
UNITED NATIONS HIGH-LEVEL MEETING ON NCDs A CALL TO ACTION ON KIDNEY DISEASE. Advancing Nephrology Around the World
2018 UNITED NATIONS HIGH-LEVEL MEETING ON NCDs A CALL TO ACTION ON KIDNEY DISEASE Advancing Nephrology Around the World Introduction The 2018 United Nations High-Level Meeting on Non-Communicable Diseases
Why can t we eliminate tuberculosis?
Why can t we eliminate tuberculosis? Neil W. Schluger, M.D. Professor of Medicine, Epidemiology and Environmental Health Sciences Columbia University Chief Scientific Officer World Lung Foundation Current
NCDs in the Post-2015 Development Agenda
NCDs in the Post-2015 Development Agenda Regional Consultation on Multisectoral Policies for Prevention and Control of NCDs in the South-East Asia Region Bengaluru, India 18-20 August 2014 Jacob Kumaresan
Universal Access to Reproductive Health: Strengthening Institutional Capacity. Why? What? And How?
Universal Access to Reproductive Health: Strengthening Institutional Capacity Why? What? And How? Presented at International Workshop on Capacity-Building in Programme Management on Population and Development,
The Strategy Development Process. Global Fund and STOP TB Consultation Istanbul, Turkey 24 July 2015
The Strategy Development Process Global Fund and STOP TB Consultation Istanbul, Turkey 24 July 2015 Structure of the current 2012-16 Global Fund Strategy The 2012-16 Global Fund Strategy.. States a forward
The Impact of the Global Economic Crisis on HIV and AIDS. Carlos Avila. 7 December 2009 UNAIDS Geneva
The Impact of the Global Economic Crisis on HIV and AIDS Carlos Avila 7 December 2009 UNAIDS Geneva Outline 1. What the monitoring system is telling us? 2. What are the driving forces? 3. What countries
Global Strategies to Improve Cancer Care and Control
Women s Empowerment Cancer Advocacy Network (WE CAN) Conference Global Strategies to Improve Cancer Care and Control Tbilisi, Georgia October 15-16, 2013 Julie R. Gralow, M.D. Jill Bennett Endowed Professor
Measles Containing Vaccines. UNICEF Supply Division Industry Consultation Meeting January 2012
Measles Containing Vaccines UNICEF Supply Division Industry Consultation Meeting 25-26 January 2012 Content Measles monovalent vaccine: Programme Updates and Procurement Overview Measles and Rubella vaccine:
7.5 South-East Asian Region: summary of planned activities, impact and costs
PART II: GLOBAL AND REGIONAL SCENARIOS FOR TB CONTROL 26 215 7.5 South-East Asian Region: summary of planned activities, impact and costs Achievements DOTS expanded rapidly in the South-East Asian Region
Fifth Global Forum on TB Vaccines
Media coverage Fifth Global Forum on TB Vaccines The Hindi http://www.thehindu.com/sci-tech/health/experts-urge-more-funds-to-tackle-tuberculosiscrisis/article22809370.ece HEALTH Experts urge more funds
TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE CONTROL OF A DUAL EPIDEMIC IN THE WHO AFRICAN REGION. Report of the Regional Director.
30 August 2007 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-seventh session Brazzaville, Republic of Congo, 27 31 August Provisional agenda item 7.8 TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE
Global strategy on viral hepatitis and regional action plan: monitoring framework and 10 core indicators
Global strategy on viral hepatitis and regional action plan: monitoring framework and 10 core indicators Antons Mozalevskis WHO Regional Office for Europe EMCDDA DRID National Expert Meeting Lisbon, 6
Strategic Plan. Briefing. Strategic Plan Annual Results. Briefing. Associate Director, Nutrition 15 June 2015 Danny Kaye. Associate Director
2014 2014 Strategic Plan Strategic Plan Annual Annual Results Results Briefing Briefing Nutrition Werner Werner Schultink Schultink Associate Director Associate Director, 15 June 2015 Nutrition 15 June
Cancer prevention and control in the context of an integrated approach
SEVENTIETH WORLD HEALTH ASSEMBLY A70/32 Provisional agenda item 15.6 13 April 2017 Cancer prevention and control in the context of an integrated approach Report by the Secretariat 1. In January 2017, the
Health literacy interventions at the service delivery/institutional level: country examples
Health literacy interventions at the service delivery/institutional level: country examples Amy Israel Global Health Thought Leadership & Policy Director Eli Lilly on behalf of International Federation
Paediatric TB: disease burden estimation and the opportunities it creates to strengthening surveillance
Paediatric TB: disease burden estimation and the opportunities it creates to strengthening surveillance Workshop 04 44 th Union World Conference on Lung Health Paris, 31 October, 2013 GLOBAL TB PROGRAMME
ASIA-PACIFIC HEART HEALTH CHARTER
ASIA-PACIFIC HEART HEALTH CHARTER The Asia-Pacific Heart Health Charter has been developed by the Asia-Pacific Heart Network in collaboration with Asia Pacific Society of Cardiology to help stem the growing
From development to delivery: Decision-making for the introduction of a new vaccine
From development to delivery: Decision-making for the introduction of a new vaccine Prince Mahidol Award Conference Bangkok, Thailand 1-2 February 2007 Dr. J.M. Okwo-Bele Department of Immunization, Vaccines
Health for Humanity 2020 Goals 2
2017 for Humanity Report Better for Humanity 2020 s 2 At Johnson & Johnson, we aspire to profoundly change the trajectory of health for humanity. Our for Humanity 2020 s, underpinned by 16 targets, focus
CONCEPT NOTE. Addressing HIV and TB Challenges: from Donor Support to Sustainable Health Systems
CONCEPT NOTE Addressing HIV and TB Challenges: from Donor Support to Sustainable Health Systems Official event in the programme of the Estonian Presidency of the Council of the European Union Co-organised
Tuberculosis Control In The South-East Asia Region: Annual TB Report 2015 By WHO Regional Office for South-East Asia READ ONLINE
Tuberculosis Control In The South-East Asia Region: Annual TB Report 2015 By WHO Regional Office for South-East Asia READ ONLINE If you are searched for the ebook Tuberculosis Control in the South-East
Message from. Dr Samlee Plianbangchang Regional Director, WHO South-East Asia. At the. Regional Review Meeting on Immunization
Message from Dr Samlee Plianbangchang Regional Director, WHO South-East Asia At the Regional Review Meeting on Immunization 19-23 July 2010 WHO/SEARO, New Delhi Regional Review Meeting on Immunization
Request for Proposals: Consultancy Evaluation, Toolkits and Economic Impact of the 22nd International AIDS Conference
Request for Proposals: Consultancy Evaluation, Toolkits and Economic Impact of the 22nd International AIDS Conference Proposals will be accepted until Friday 6 April 2018 1. About the International AIDS
Principle of Tuberculosis Control. CHIANG Chen-Yuan MD, MPH, DrPhilos
Principle of Tuberculosis Control CHIANG Chen-Yuan MD, MPH, DrPhilos Estimated global tuberculosis burden 2015 an estimated 10.4 million incident cases of TB (range, 8.7 million 12.2 million) 142 cases
Report of the Executive Director
Report of the Executive Director Context for the 19 th Board meeting Financial and economic crisis 2008 Ambitious demand and disbursement targets met Strong results and progress towards MDGs ( Green Report
2. Treatment coverage: 3. Quality of care: 1. Access to diagnostic services:
The theme for World TB Day 2014 is Reach the missed 3 million. Every year 3 million people who fall ill with TB are missed by health systems and do not always get the TB services that they need and deserve.
HARM REDUCTION IN ASIA. Adeeba Kamarulzaman University of Malaya, Kuala Lumpur
HARM REDUCTION IN ASIA Adeeba Kamarulzaman University of Malaya, Kuala Lumpur Prevalence of HIV among IDUs: 2007 DU identified in 148 countries 15.9 million PWID No estimate of HIV prevalence 0%
Conducting High Quality TB Clinical Trials in China
Conducting High Quality TB Clinical Trials in China Jing Bao, MD, PhD St. George Hospital, London, 10/21/2011 Medical Officer, Contractor, HJF/NIAID/DAIDS Baoj@mail.nih.gov Topics to be covered TB epidemic
World Health Organization 2013
World Health Organization 2013 All rights reserved. Publications of the World Health Organization are available on the WHO web site (www.who.int) or can be purchased from WHO Press, World Health Organization,
Center for Global Health. CDC Global Health Saving Lives Overseas, Protecting Americans at Home
Center for Global Health CDC Global Health Saving Lives Overseas, Protecting Americans at Home CDC Overview Part of the U.S. Department of Health and Human Services, CDC is the nation s leading public